Biotech Roundup: Kadmon Debt, Hemo Data, Loose Lips & More
Xconomy
JUNE 17, 2016
Despite technical differences and the early nature of the data that made comparison difficult, Wall Street declared Spark this week’s winner. —The FDA approved a cholera vaccine , Vaxchora, giving Redwood City, CA-based PaxVax its second commercial product. UniQure’s shares fell more than 16 percent. right now. .
Let's personalize your content